Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

841
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
841
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

742
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
742
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

66.8K
Overview
66.8K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

651
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
651
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

1.6K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.6K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

1.5K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Celldetective, an AI-enhanced image analysis tool for unraveling dynamic cell interactions.

eLife·2026
Same author

Optimizing nanobody-based molecules targeting mesothelin: Exploring format, valency, size, and half-life for next-generation cancer theranostics.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

From variant detection to interpretation in idiopathic erythrocytosis: A structured approach applied to a clinical cohort.

British journal of haematology·2026
Same author

Novel therapeutic targets at the crossroad between epigenetics and signal transduction pathways in B-cell lymphomas.

Clinical and experimental medicine·2026
Same author

Sequential BV-AVD Therapy in Richter Transformation: Insights Into the Management of Elderly Patients.

Hematological oncology·2026
Same author

B-cell and plasma cell proliferations associated with T follicular helper cell lymphomas: clinical-pathological and genetic features.

Virchows Archiv : an international journal of pathology·2026

Related Experiment Video

Updated: Jun 3, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.2K

Decoupling Individual Host Response and Immune Cell Engager Cytotoxic Potency.

Cristina Gonzàlez Gutierrez1, Adrien Aimard2, Martine Biarnes-Pélicot1

  • 1Aix-Marseille Univ., CNRS, INSERM, LAI, Centuri Living Systems, 13009 Marseille, France.

ACS Nano
|January 10, 2025
PubMed
Summary

This study introduces a model to understand how bispecific antibodies (bsAbs) engage Natural Killer (NK) cells to kill cancer. The model shows that the density of bsAbs connecting cells is key to triggering cancer cell death.

Keywords:
NK cellbispecific antibodiesimmunotherapymultiscale modelnanoscale cooperativitytripartite interaction

More Related Videos

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

8.9K
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

8.6K

Related Experiment Videos

Last Updated: Jun 3, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.2K
Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

8.9K
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

8.6K

Area of Science:

  • Immunology
  • Biotechnology
  • Cancer Research

Background:

  • Immune cell engagers, often antibody-based, are crucial for cancer immunotherapy.
  • Understanding the influence of molecular and cellular factors on engager efficiency is limited.
  • Disentangling host immune cell roles and engager biophysical properties is vital for improved design.

Purpose of the Study:

  • To investigate the efficiency of bispecific antibodies (bsAbs) in harnessing Natural Killer (NK) cell-mediated cytotoxicity against cancer.
  • To develop a model that rationalizes the dose-response of bsAbs based on molecular and cellular parameters.
  • To decouple donor-specific responses from immune engager characteristics for optimized design.

Main Methods:

  • Evaluated 6 novel bispecific antibodies (bsAbs) combining anti-HER2 and anti-CD16 nanobodies.
  • Collected in vitro cytotoxicity data using primary human NK cells against target cell lines with varying HER2 antigen densities.
  • Developed a multiscale model linking bsAb density to cytotoxic response.

Main Results:

  • Observed a wide range of bsAb dose responses in cytotoxicity assays.
  • The model identified bsAb density bridging immune and target cells as the primary trigger for cytotoxicity.
  • Introduced 'surface cooperativity' and 'bridge density threshold' parameters to rank antibodies and predict potency.

Conclusions:

  • The developed model provides a framework to understand and predict the efficacy of bsAbs in NK cell-mediated cancer immunotherapy.
  • The model successfully decouples donor-dependent responses from immune engager properties.
  • This approach aids in rationalizing the design of more efficient immune engagers for cancer treatment.